Implications of excess weight in the cardiotoxicity of anthracyclines and trastuzumab in breast cancer

Arch Cardiovasc Dis. 2017 Feb;110(2):69-71. doi: 10.1016/j.acvd.2016.12.004. Epub 2017 Feb 16.
No abstract available

Keywords: Anthracycline; Breast cancer; Cancer du sein; Cardiotoxicity; Cardiotoxicité; Obesity; Obésité; Overweight; Surpoids; Trastuzumab.

Publication types

  • Editorial

MeSH terms

  • Anthracyclines / adverse effects*
  • Antibiotics, Antineoplastic / adverse effects*
  • Antineoplastic Agents, Immunological / adverse effects*
  • Body Mass Index
  • Breast Neoplasms / drug therapy*
  • Cardiotoxicity
  • Female
  • Heart Diseases / chemically induced*
  • Heart Diseases / epidemiology
  • Heart Diseases / physiopathology
  • Humans
  • Obesity / diagnosis
  • Obesity / epidemiology*
  • Obesity / physiopathology
  • Risk Factors
  • Trastuzumab / adverse effects*
  • Treatment Outcome
  • Weight Gain

Substances

  • Anthracyclines
  • Antibiotics, Antineoplastic
  • Antineoplastic Agents, Immunological
  • Trastuzumab